Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-13

Clinical Trial Update: Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations

View source ↗

Summary

This clinical study evaluates immunogenicity and safety of a lyophilized vero cell–derived human rabies vaccine in special populations and is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lyophilized Vero Cell-Derived Human Rabies Vaccine (Rabies vaccine (vero cell-derived))

Snippet

Sponsor: Liaoning Chengda Biotechnology CO., LTD | Conditions: Rabies Exposure, Immunocompromised | Status: RECRUITING